公司問答丨嘉必優:ARA和DHA產品目前主要應用於嬰幼兒配方食品領域
格隆匯5月25日丨有投資者在互動平台向嘉必優公司提問:募資建設的粉劑和油劑項目,國內下游奶粉客户是否都需要進行驗證?國外客户是否都需要驗證?目前驗證的進度到什麼程度了?
嘉必優迴應:公司的ARA和DHA產品目前主要應用於嬰幼兒配方食品領域,食品安全的要求尤為嚴格,產品生產地址變更、工藝及原材料的重大變更都需要得到監管部門和客户的審核和驗證。這樣的要求不分國內客户和國外客户,目前公司給國外客户提供的油劑產品沒有發生重大變更,因此暫時不存在客户驗證的問題,新的粉劑生產線正在積極推動主要客户的驗證工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.